MX2015003665A - Microcapsulas biodegradables que contienen material de relleno. - Google Patents

Microcapsulas biodegradables que contienen material de relleno.

Info

Publication number
MX2015003665A
MX2015003665A MX2015003665A MX2015003665A MX2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A
Authority
MX
Mexico
Prior art keywords
filling material
microcapsules containing
biodegradable
containing filling
biodegradable microcapsules
Prior art date
Application number
MX2015003665A
Other languages
English (en)
Inventor
Kinam Park
Christopher A Rhodes
Original Assignee
Akina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina Inc filed Critical Akina Inc
Publication of MX2015003665A publication Critical patent/MX2015003665A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Abstract

Se describen microcápsulas biodegradables que incluyen una cubierta de polímero biodegradable y un material de relleno. La cubierta de polímero completamente abarca el material de relleno. El material de relleno puede incluir una o más micropartículas biodegradables o un agente terapéutico, o ambos.
MX2015003665A 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno. MX2015003665A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Publications (1)

Publication Number Publication Date
MX2015003665A true MX2015003665A (es) 2016-03-08

Family

ID=50341971

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015003665A MX2015003665A (es) 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno.
MX2019002575A MX2019002575A (es) 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019002575A MX2019002575A (es) 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno.

Country Status (9)

Country Link
US (3) US20150265541A1 (es)
EP (1) EP2897593A4 (es)
JP (2) JP2015532928A (es)
KR (1) KR20150090038A (es)
AU (3) AU2013317899A1 (es)
BR (1) BR112015006087A2 (es)
HK (1) HK1214127A1 (es)
MX (2) MX2015003665A (es)
WO (1) WO2014047439A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889193B2 (en) 2010-02-25 2014-11-18 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
WO2012039979A2 (en) 2010-09-10 2012-03-29 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
US9327037B2 (en) 2011-02-08 2016-05-03 The Johns Hopkins University Mucus penetrating gene carriers
KR101811917B1 (ko) 2012-01-19 2017-12-22 더 존스 홉킨스 유니버시티 점액 침투 강화를 나타내는 나노 입자 제형
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
EA030318B1 (ru) 2012-03-16 2018-07-31 Дзе Джонс Хопкинс Юниверсити Конъюгаты нелинейного мультиблочного сополимера с лекарственным средством для доставки активных агентов
EP2844227B1 (en) 2012-05-03 2020-11-18 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
CA2872519C (en) 2012-05-04 2017-09-05 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
AU2016211696B2 (en) 2015-01-27 2018-05-10 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
WO2017197046A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. C3-carbon linked glutarimide degronimers for target protein degradation
WO2017197055A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
AU2017290593A1 (en) 2016-06-27 2019-01-03 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
CN109789143A (zh) 2016-07-01 2019-05-21 G1治疗公司 基于嘧啶的抗增殖剂
BR112019008463B1 (pt) 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
BR112019008475B1 (pt) * 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
JP2021519337A (ja) 2018-03-26 2021-08-10 シー４ セラピューティクス， インコーポレイテッド Ｉｋａｒｏｓの分解のためのセレブロン結合剤
JP2021535112A (ja) 2018-08-20 2021-12-16 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
EP3866773A4 (en) 2018-10-16 2022-10-26 Georgia State University Research Foundation, Inc. CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
EP1404516A2 (en) * 2000-12-13 2004-04-07 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
CA2582374A1 (en) * 2004-10-04 2006-04-20 Qlt Usa, Inc. Ocular delivery of polymeric delivery formulations
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
EP1931387A4 (en) * 2005-09-07 2012-07-11 Southwest Res Inst BIODEGRADABLE MICROTEILED PHARMACEUTICAL FORMULATIONS WITH IMPROVED RELEASE RATES
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CN101809446B (zh) * 2007-09-27 2013-11-27 株式会社三养生物制药 溶胶-凝胶相可逆性水凝胶模板及其应用
US20130316010A1 (en) * 2010-10-18 2013-11-28 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
WO2014047439A1 (en) 2014-03-27
HK1214127A1 (zh) 2016-10-07
KR20150090038A (ko) 2015-08-05
EP2897593A4 (en) 2016-04-06
US20200390715A1 (en) 2020-12-17
JP2015532928A (ja) 2015-11-16
BR112015006087A2 (pt) 2017-07-04
AU2013317899A1 (en) 2015-05-07
MX2019002575A (es) 2019-10-30
JP2019014729A (ja) 2019-01-31
EP2897593A1 (en) 2015-07-29
AU2018204552A1 (en) 2018-07-12
AU2013317899A8 (en) 2015-05-28
US20180185296A1 (en) 2018-07-05
US20150265541A1 (en) 2015-09-24
AU2020202735A1 (en) 2020-05-14

Similar Documents

Publication Publication Date Title
MX2019002575A (es) Microcapsulas biodegradables que contienen material de relleno.
HK1218088A1 (zh) 包括分配劑和藥劑源的氣霧劑
EP2872118A4 (en) HYDROGEL FUEL CAPSULE, FORMULATIONS AND METHOD FOR THE MANUFACTURE THEREOF
HK1207978A1 (en) Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
HK1194279A1 (zh) 藥丸盒、藥物管理系統和藥物分配系統
IL237101B (en) A secondary part, a system that includes a dental implant and the secondary part, and a package that includes the system
EP2906146A4 (en) CAPSULE EXPANDER DEVICES, SYSTEMS, AND METHODS FOR INHIBITING CAPSOLUTION AND STABILIZATION OF THE CAPSULE
EP2893974A4 (en) WATER ABSORPTION RESIN, WATER ABSORPTION BODY, AND WATER ABSORPTION PRODUCT
PT2991511T (pt) Material vaporizável e cápsula
EP2828338A4 (en) ORGANOMODIFIED SILICONE POLYMERS AND HYDROGELES THEREWITH
HUE057392T2 (hu) Fogyasztásra kész termék fertõtlenítése, sterilizálása és csomagolása
EP2908868A4 (en) DEODORIZING AND DISINFECTING CONTAINER
PH12015500384A1 (en) Polyolefin composition
EP2905319A4 (en) TREATMENT AGENT AND COSMETIC MATERIAL CONTAINING A COMODIFIED ORGANOPOLYSILOXANE
BR112014029212A2 (pt) composição de agente de clarificação. composição de resina e artigo moldado
HK1211220A1 (en) A pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
EP2682096A4 (en) COSMETIC BASE MATERIAL AND COSMETICS ITEMS WITH THIS COSMETIC BASE MATERIAL
ZA201703337B (en) Microcapsules containing a gas-generating photolabile polymer and uses thereof
HK1181959A2 (en) A heating device with fragrance plastic capsule and the fragrance plastic capsule thereof
EP3654926C0 (en) POLYMER ENCAPSULATED FRAGRANCES WITH CONTROLLED RELEASE
EP2907798A4 (en) GAS PRODUCING MATERIAL AND MICROPUMP
GB201307944D0 (en) Vaporisable material and capsule
EP2663293A4 (en) RELEASED VISKÖSE POLYMERTABLETTE AND USE METHOD THEREFOR
HK1204282A1 (en) Drug composition, and soft capsule containing same
GB201217123D0 (en) Hard toothpaste rounded pills with the special toothbrush dispersal and loadingmechanism